OXFORD ASSET MANAGEMENT LLP - INNOVATE BIOPHARMACEUTICLS I ownership

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q4 2018$330,000142,8890.01%
Other shareholders
INNOVATE BIOPHARMACEUTICLS I shareholders Q3 2023
NameSharesValueWeighting ↓
Hillview Capital Advisors, LLC 19,610$45,0000.27%
Magnus Financial Group LLC 49,500$114,0000.03%
OXFORD ASSET MANAGEMENT LLP 142,889$330,0000.01%
GSA CAPITAL PARTNERS LLP 26,500$61,0000.01%
FIRST QUADRANT LLC/CA 23,700$55,0000.00%
Tower Research Capital LLC (TRC) 4,400$10,0000.00%
MEEDER ASSET MANAGEMENT INC 2,572$6,0000.00%
SIMPLEX TRADING, LLC 1,251$2,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 35,685$82,0000.00%
UBS Group AG 13,791$32,0000.00%
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders